Brookstone Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.62M Buy
8,923
+795
+10% +$322K 0.05% 325
2025
Q1
$4.04M Buy
8,128
+5,798
+249% +$2.89M 0.06% 298
2024
Q4
$1.21M Sell
2,330
-228
-9% -$119K 0.02% 478
2024
Q3
$1.58M Buy
2,558
+76
+3% +$47K 0.02% 421
2024
Q2
$1.38M Sell
2,482
-1,905
-43% -$1.06M 0.02% 434
2024
Q1
$2.55M Buy
4,387
+3,142
+252% +$1.83M 0.05% 321
2023
Q4
$661K Sell
1,245
-1,812
-59% -$962K 0.01% 540
2023
Q3
$1.44M Sell
3,057
-624
-17% -$293K 0.03% 363
2023
Q2
$1.89M Buy
3,681
+187
+5% +$96.1K 0.04% 316
2023
Q1
$2.06M Sell
3,494
-153
-4% -$90K 0.04% 320
2022
Q4
$1.95M Sell
3,647
-274
-7% -$147K 0.04% 320
2022
Q3
$1.96M Buy
3,921
+120
+3% +$60.1K 0.05% 291
2022
Q2
$2.11M Sell
3,801
-370
-9% -$205K 0.05% 281
2022
Q1
$2.44M Sell
4,171
-409
-9% -$240K 0.05% 265
2021
Q4
$2.78M Buy
4,580
+245
+6% +$149K 0.05% 223
2021
Q3
$2.49M Buy
4,335
+151
+4% +$86.6K 0.04% 234
2021
Q2
$2.15M Buy
4,184
+2,554
+157% +$1.31M 0.04% 252
2021
Q1
$744K Sell
1,630
-638
-28% -$291K 0.03% 288
2020
Q4
$1.06M Sell
2,268
-248
-10% -$115K 0.04% 223
2020
Q3
$1.11M Buy
2,516
+578
+30% +$255K 0.05% 199
2020
Q2
$702K Buy
1,938
+1,030
+113% +$373K 0.04% 197
2020
Q1
$258K Sell
908
-363
-29% -$103K 0.01% 274
2019
Q4
$413K Buy
1,271
+167
+15% +$54.3K 0.02% 299
2019
Q3
$322K Sell
1,104
-4
-0.4% -$1.17K 0.02% 326
2019
Q2
$325K Sell
1,108
-136
-11% -$39.9K 0.02% 354
2019
Q1
$341K Buy
+1,244
New +$341K 0.02% 317
2018
Q4
Sell
-831
Closed -$203K 393
2018
Q3
$203K Buy
+831
New +$203K 0.02% 385
2018
Q2
Sell
-975
Closed -$201K 405
2018
Q1
$201K Buy
+975
New +$201K 0.02% 330
2015
Q4
Sell
-229
Closed -$28K 816
2015
Q3
$28K Hold
229
0.01% 614
2015
Q2
$30K Buy
+229
New +$30K ﹤0.01% 663